Skip to product information
1 of 2

Elanco

Vira Shield 6+VL5

Vira Shield 6+VL5

Regular price $144.92 USD
Regular price Sale price $144.92 USD
Sale Sold out
Shipping calculated at checkout.
NOTIFY ME WHEN IN STOCK
Size
Please see shipping information regarding vaccines before placing order.
Killed virus and bacterin for the protection of healthy cattle against IBR, PI3, BRSV, cytopathic and noncytopathic BVD Type 1, noncytopathic BVD Type 2, Vibrio and the 5 most common strains of Lepto. For use in all classes of cattle, even pregnant cows and calves nursing pregnant cows. Vaccinate dairy cows during the dry off period. Features Xtend SP adjuvant.

Dosage: 5 ml subcut 2-4 weeks prior to breeding, revaccinate with Vira Shield 6 in 4-5 weeks. Revaccinate annually. Milk reduction and transient depression may be observed in lactating dairy cows for 3-6 days following vaccination. 60-day slaughter withdrawal.

Manufacturer and/or Label Information

ELANCO US, INC.
Farm Animal Business
Distributed by ELANCO US, INC.
1447 140TH ST., LARCHWOOD, IA, 51241
Customer Service: 800-782-8977
Main Switchboard: 317-433-4800
Technical Service: 800-843-4441
Website: www.elanco.us
Email: elanco@elanco.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
VIRA SHIELD™ 6+VL5

Elanco US (Farm Animal)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use In Animals Only

INDICATIONS: This product has been shown to be effective for the vaccination of healthy cattle against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. The duration of immunity against BVD Type 2 is as at least 11 months and C. fetus is at least one year. The duration of immunity for the other antigens has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.

ADJUVANT: Xtend™ SP.

DIRECTIONS: Shake well before using. Administer 5 mL subcutaneously 2 to 4 weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate with Vira Shield 6 (Code 1185.20) in 4 to 5 weeks. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For advice on revaccination, contact a veterinarian.

PRECAUTIONS: Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3 to 6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN 196/44B6.20

Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441

Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses

50 mL

YL102481A

50 Doses

250 mL

YL102481B

CPN: 1114096.5

COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Products

Dimensions

Care information

View full details